Skip to main content

Market Overview

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – BOLD, AKS, INST, THOR

Share:

NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Audentes Therapeutics, Inc. (NASDAQ:BOLD)
The investigation concerns whether Audentes and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Audentes to Astellas Pharma Inc. for $60.00 per share. If you are an Audentes shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/audentes-therapeutics-inc-bold-stock-merger-astellas-pharma/.

AK Steel Holding Corporation (NYSE:AKS)
The investigation concerns whether AK Steel and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of AK Steel to Cleveland-Cliffs Inc. If you are an AK Steel shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/ak-steel-holding-corporation-aks-stock-merger-cliffs/.

Instructure, Inc. (NYSE:INST)
The investigation concerns whether Instructure and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Instructure to Thoma Bravo, LLC for $47.60 per share. If you are an Instructure shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/instructure-inc-inst-stock-merger-thoma-bravo.

Synthorx, Inc. (NASDAQ:THOR)
The investigation concerns whether Synthorx and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Synthorx to Sanofi for $68.00 per share. If you are a Synthorx shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/synthorx-inc-thor-stock-merger-sanofi/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Primary Logo

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com